Worthylake R, Wiley H S
Division of Cell Biology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah 84132, USA.
J Biol Chem. 1997 Mar 28;272(13):8594-601. doi: 10.1074/jbc.272.13.8594.
The epidermal growth factor receptor (EGF-R) is known to transmodulate the activity and level of the erbB-2/neu protein in several epithelial cell lines. We therefore determined which structural features of the EGF-R were important in transmodulating erbB-2. We found that the addition of EGF to nontransformed epithelial cells resulted in down-regulation of erbB-2 with the same kinetics and similar extent as the EGF-R. By using cells expressing a series of EGF-R modified by site-directed mutagenesis, we found that EGF-R tyrosine kinase activity was not necessary for down-regulation of erbB-2, but receptor sequences between 899 and 958 in the EGF-R were required. To determine whether transmodulation was associated with activation of erbB-2, tyrosine phosphorylation of erbB-2 was determined following addition of EGF. Again, phosphorylation of erbB-2 following EGF addition did not require the intrinsic tyrosine kinase activity of the EGF-R, but did require sequences between 899 and 958. To determine the localization of EGF-R and erbB-2 following EGF addition, the relative distribution of the two receptors was evaluated by fluorescence microscopy. Surprisingly, the majority of erbB-2 was found in small cytoplasmic vesicles, whereas the EGF-R was predominantly found on the cell surface. Addition of EGF resulted in a redistribution and consequent colocalization of both receptors in endosomal and lysosomal structures. We conclude that activation and transmodulation of erbB-2 does not require intrinsic tyrosine kinase activity of the EGF-R, but does require sequences in the EGF-R which regulate its trafficking.
已知表皮生长因子受体(EGF-R)可调节几种上皮细胞系中erbB-2/neu蛋白的活性和水平。因此,我们确定了EGF-R的哪些结构特征在调节erbB-2中起重要作用。我们发现,向未转化的上皮细胞中添加EGF会导致erbB-2的下调,其动力学和程度与EGF-R相同。通过使用表达一系列经定点诱变修饰的EGF-R的细胞,我们发现EGF-R酪氨酸激酶活性对于erbB-2的下调不是必需的,但EGF-R中899至958之间的受体序列是必需的。为了确定调节是否与erbB-2的激活相关,在添加EGF后测定erbB-2的酪氨酸磷酸化。同样,添加EGF后erbB-2的磷酸化不需要EGF-R的内在酪氨酸激酶活性,但确实需要899至958之间的序列。为了确定添加EGF后EGF-R和erbB-2的定位,通过荧光显微镜评估两种受体的相对分布。令人惊讶的是,大多数erbB-2存在于小的细胞质囊泡中,而EGF-R主要存在于细胞表面。添加EGF导致两种受体在内体和溶酶体结构中重新分布并因此共定位。我们得出结论,erbB-2的激活和调节不需要EGF-R的内在酪氨酸激酶活性,但确实需要EGF-R中调节其运输的序列。